Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of April 8, 2026, STAAR Surgical Company (STAA) trades at $21.09, marking a 0.62% gain from the previous closing price. The ophthalmic medical device developer has traded in a relatively tight range this month, with no major unanticipated news driving significant volatility as of this analysis. No recent earnings data is available for STAA at the time of writing, so market participants are focusing on technical levels and broader sector trends to gauge near-term price action. This analysis co
Can STAAR (STAA) Stock Go Higher | Price at $21.09, Up 0.62% - RSI Overbought Stocks
STAA - Stock Analysis
4,911 Comments
1,031 Likes
1
Richardd
New Visitor
2 hours ago
Anyone else trying to catch up?
👍 112
Reply
2
Zoey
Registered User
5 hours ago
Who else is thinking deeper about this?
👍 57
Reply
3
Junita
Active Reader
1 day ago
I feel like I need to discuss this with someone.
👍 76
Reply
4
Bensyn
Returning User
1 day ago
Anyone else curious but confused?
👍 41
Reply
5
Edon
Engaged Reader
2 days ago
Who else is here just trying to learn?
👍 271
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.